SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 74 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $394,000 | -72.4% | 21,933 | -83.1% | 0.00% | -71.4% |
Q1 2017 | $1,425,000 | -68.3% | 129,510 | -61.0% | 0.01% | -68.2% |
Q4 2016 | $4,500,000 | +42.2% | 332,072 | +29.2% | 0.02% | +37.5% |
Q3 2016 | $3,165,000 | -72.2% | 257,022 | -75.2% | 0.02% | -72.4% |
Q2 2016 | $11,381,000 | -35.7% | 1,037,372 | -35.9% | 0.06% | -34.8% |
Q1 2016 | $17,699,000 | -44.6% | 1,619,390 | -12.4% | 0.09% | -46.7% |
Q4 2015 | $31,966,000 | -1.6% | 1,848,824 | +13.1% | 0.17% | -5.6% |
Q3 2015 | $32,478,000 | +171.1% | 1,634,519 | +124.2% | 0.18% | +205.2% |
Q2 2015 | $11,981,000 | +176.1% | 729,206 | +161.6% | 0.06% | +190.0% |
Q1 2015 | $4,340,000 | +17.3% | 278,801 | +7.7% | 0.02% | +25.0% |
Q4 2014 | $3,699,000 | +183.2% | 258,988 | +28.9% | 0.02% | +166.7% |
Q3 2014 | $1,306,000 | -22.2% | 200,883 | -17.4% | 0.01% | -25.0% |
Q2 2014 | $1,679,000 | +15.1% | 243,187 | +19.0% | 0.01% | 0.0% |
Q1 2014 | $1,459,000 | +213.8% | 204,321 | +312.4% | 0.01% | +166.7% |
Q4 2013 | $465,000 | – | 49,540 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 2,819,708 | $29,607,000 | 8.99% |
Rubric Capital Management LP | 577,900 | $6,068,000 | 1.25% |
Malaga Cove Capital, LLC | 84,241 | $882,000 | 0.53% |
NEA Management Company, LLC | 1,258,507 | $13,214,000 | 0.48% |
CLARK ESTATES INC/NY | 250,000 | $2,625,000 | 0.45% |
AlphaMark Advisors, LLC | 98,400 | $1,033,000 | 0.44% |
Ativo Capital Management LLC | 138,032 | $1,449,000 | 0.40% |
TFS CAPITAL LLC | 83,694 | $879,000 | 0.34% |
GLOBEFLEX CAPITAL L P | 103,949 | $1,091,000 | 0.27% |
Bowling Portfolio Management LLC | 135,021 | $1,418,000 | 0.21% |